Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2024-12-10 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
关于召开2024年第一次临时股东大会的通知公告
AGM Information Classification · 95% confidence The document is a detailed notice and announcement regarding the convening of the 2024 first extraordinary general meeting of shareholders (临时股东大会) of 华邦生命健康股份有限公司. It includes information about the meeting date, voting procedures, proposals to be voted on, and instructions for shareholders. The content is focused on the meeting logistics and agenda items, including proposals related to bond issuance and amendments to company rules. There is no financial data, earnings information, or management discussion of financial results. The document is not a report itself but an announcement and notice about the meeting and its agenda. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual or Extraordinary General Meeting.
2024-12-10 Chinese
公司章程（2024年12月）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 华邦生命健康股份有限公司 (Huapont Life Sciences Co., Ltd.). It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, share transfer, shareholder meetings, and other governance matters. It references Chinese company law and securities law, and includes historical amendments approved at various shareholder meetings. The content is a comprehensive governance document outlining internal rules and procedures of the company rather than a financial report, announcement, or meeting minutes. Therefore, it fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not a brief announcement or summary.
2024-12-10 Chinese
独立董事关于第八届董事会第二十一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on several company matters including credit limits, guarantees, related party transactions, foreign exchange business, and conditions for non-public issuance of exchangeable corporate bonds. It references compliance with laws and regulations and is dated December 10, 2024. The document is a formal opinion letter from independent directors regarding agenda items to be submitted to a shareholders' meeting. It does not contain financial statements or detailed financial results, nor is it a report or announcement of voting results. It is a governance-related document expressing independent directors' views on corporate governance and compliance matters. Therefore, the most appropriate classification is Board/Management Information (MANG), as it relates to board-level opinions and governance matters.
2024-12-10 Chinese
关于非公开发行可交换公司债券的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's plan to conduct a non-public issuance of exchangeable corporate bonds. It details the terms, conditions, authorization requests, and regulatory compliance related to this bond issuance. The text does not contain actual financial statements or results but rather outlines the issuance plan and seeks shareholder authorization. The document length is 3620 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this is a Capital/Financing Update (CAP) filing, as it relates to company fundraising and capital structure changes.
2024-12-10 Chinese
股东会议事规则（2024年12月）
Governance Information Classification · 95% confidence The document is titled as "股东会议事规则" which translates to "Shareholders Meeting Rules" or "Rules of Procedure for Shareholders' Meetings". It contains detailed provisions about the convening, notification, proposal submission, voting, and decision-making processes of shareholders' meetings. It includes legal references, procedural rules, voting rights, and other governance-related content. There is no indication that this is an announcement of a meeting, a transcript, or a financial report. Instead, it is a governance document detailing internal rules and procedures for shareholder meetings, which fits the definition of Governance Information (CGR). The document length is substantial and contains detailed governance rules, not just an announcement or summary.
2024-12-10 Chinese
第八届董事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 21st meeting of the 8th Board of Directors of 华邦生命健康股份有限公司. It includes multiple agenda items such as approval of credit limits, related party transactions, foreign exchange business, amendments to company bylaws, and a non-public issuance of exchangeable corporate bonds. The document also mentions that these resolutions will be submitted to the 2024 first extraordinary shareholders meeting for approval. The content focuses on board meeting decisions and governance matters rather than financial results or audit opinions. It is not a full annual or interim report, nor an earnings release or audit report. It is not a proxy solicitation or voting results announcement. The document is a formal disclosure of board meeting resolutions, which fits the category of Board/Management Information (MANG). The length (6129 characters) and detailed content confirm it is not a brief announcement or a report publication notice. Therefore, the classification is MANG with high confidence.
2024-12-10 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.